Heute mit einem Plus von 48%. Weis jemand warum ?
Top-News
Senetek
Beiträge:
4
Zugriffe: 2.102 / Heute: 3
Zugriffe: 2.102 / Heute: 3
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI USA Banks UCITS ETF 1D
Perf. 12M: +70,66%
Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C
Perf. 12M: +66,39%
Xtrackers MSCI Pakistan Swap UCITS ETF 1C
Perf. 12M: +61,91%
Xtrackers MSCI USA Communication Services UCITS ETF 1D
Perf. 12M: +53,61%
Xtrackers MSCI World Communication Services UCITS ETF 1C
Perf. 12M: +50,55%
sogar 52% Plus. Aber letzte News vom 9.9.03. Nichts zu finden.
Aber ob das 50% rechtfertigt?
Senetek PLC Launches kinetinplus.com Web Site
Friday September 19, 12:18 pm ET
NAPA, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - News), www.senetekplc.com , a biopharmaceutical company focused on developing and marketing products that meet under-met consumer needs for aging well, today announced that it has launched an interactive Web site for the direct purchase of its new, full Kinetin Plus line at http://www.kinetinplus.com .
The Web site brings interested consumers complete information about Kinetin, including data from clinical studies conducted at a prestigious university, and scientific photographs of the results of the 48-week study. The site allows interested consumers to enroll in the Kinetin Plus(TM) "Looking Good Feels Good" program and offers for sale eight Kinetin Plus(TM) products. The site was developed in conjunction with the Company's new infomercial for Kinetin Plus(TM), which recently completed a pilot media test schedule.
Senetek's patented ingredient, Kinetin, is a naturally occurring cytokinin that has proven to be effective in treating the appearance of aging skin with minimal side effects. Senetek's eleven current Kinetin licensees include ICN Pharmaceuticals,Inc., Revlon, Inc. and The Body Shop, which have successfully introduced Kinetin in their respective channels of distribution. The infomercial and new Web site are Senetek's first channels for selling its popular Kinetin products directly to consumers.
Visit Senetek PLC's Web site: http://www.senetekplc.com .
Senetek PLC Investor Relations Contact:
1-707-226-3900 ext. 102
E-Mail: Pknopick@eandecommunications.com
Safe Harbor Statement:
This news release may contain statements that may be considered "forward-looking
statements" under the federal securities laws, including statements concerning the
eventual national roll-out of the infomercial, the potential success of the Kinetin Plus
product line and the hoped-for benefits of this product launch.
Senetek PLC Launches kinetinplus.com Web Site
Friday September 19, 12:18 pm ET
NAPA, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - News), www.senetekplc.com , a biopharmaceutical company focused on developing and marketing products that meet under-met consumer needs for aging well, today announced that it has launched an interactive Web site for the direct purchase of its new, full Kinetin Plus line at http://www.kinetinplus.com .
The Web site brings interested consumers complete information about Kinetin, including data from clinical studies conducted at a prestigious university, and scientific photographs of the results of the 48-week study. The site allows interested consumers to enroll in the Kinetin Plus(TM) "Looking Good Feels Good" program and offers for sale eight Kinetin Plus(TM) products. The site was developed in conjunction with the Company's new infomercial for Kinetin Plus(TM), which recently completed a pilot media test schedule.
Senetek's patented ingredient, Kinetin, is a naturally occurring cytokinin that has proven to be effective in treating the appearance of aging skin with minimal side effects. Senetek's eleven current Kinetin licensees include ICN Pharmaceuticals,Inc., Revlon, Inc. and The Body Shop, which have successfully introduced Kinetin in their respective channels of distribution. The infomercial and new Web site are Senetek's first channels for selling its popular Kinetin products directly to consumers.
Visit Senetek PLC's Web site: http://www.senetekplc.com .
Senetek PLC Investor Relations Contact:
1-707-226-3900 ext. 102
E-Mail: Pknopick@eandecommunications.com
Safe Harbor Statement:
This news release may contain statements that may be considered "forward-looking
statements" under the federal securities laws, including statements concerning the
eventual national roll-out of the infomercial, the potential success of the Kinetin Plus
product line and the hoped-for benefits of this product launch.
aber ich glaube es muß etwas anderes sein.
Habe auch noch keine E-mail von der Investor-Relation Abteilung erhalten.
Sonst sind die immer fix.
Habe auch noch keine E-mail von der Investor-Relation Abteilung erhalten.
Sonst sind die immer fix.
Es gibt keine neuen Beiträge.
Neueste Beiträge aus dem SENETEK PLC Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 7 | Senetek | Janasde | E8DEF285 | 06.08.07 09:50 | ||
| 29 | Was war denn heute bei DOR los? | Eskimato | Eskimato | 02.03.05 19:28 | ||
| 3 | sntk 888791 nun hat er recht | E8DEF285 | E8DEF285 | 25.03.04 16:04 | ||
| 5 | Senetek ( 888791 ) | Meiko | all time high | 10.03.04 18:19 | ||
| 1 | senetek ein neuer frühling wkn 888791 | E8DEF285 | E8DEF285 | 04.02.04 13:02 |
